透過您的圖書館登入
IP:3.16.70.101
  • 學位論文

鹼性抗生胜肽Indolicidin及其類似物對於人 類皮膚細胞及人類表皮皮膚癌細胞之影響

Biological Activities of Indolicidin and Its’ Analogues on Fibroblast, Keratinocyte and Human Epidermoid Carcinoma

指導教授 : 謝瑞香

摘要


許多文獻指出,從牛的嗜中性白血球中所分離出來的鹼性抗生胜 肽Indolicidin 具廣效抗菌性,可對抗真菌、細菌或病毒。越來越多研 究發現一些鹼性抗生胜肽其實也存在對癌細胞的抗癌活性,因此本實 驗想探討Indolicidin 及其類似物IL-K7、IL-F89 及IL-K7F89 是否會 對人類表皮膚癌細胞產生抗癌活性或對正常皮膚細胞存在細胞毒 性。 實驗希望找出適合的濃度與胜肽,對皮膚癌細胞具高抗癌活性並 且對正常皮膚細胞擁有低細胞毒性,所以本實驗選用三種濃度:60μM、 30μM 和10μM 來進行實驗,並對利用PI 染色及TUNEL assay 來觀察 細胞受胜肽作用後是經由凋亡或是壞死而導致死亡。 由實驗結果得知10μM 的IL-K7F89 有高抗癌細胞活性能抑制人 類表皮皮膚癌細胞的生長,只對角質細胞及纖維母細胞產生些微的細 胞毒性。由PI 染色和TUNEL assay 結果得知,IL 及其類似物會造成 細胞壞死並非凋亡。之前研究也證實IL-K7F89 具有比IL 高的抗菌活 性也具備比IL 低的溶血活性,結合這些優點或許未來可將其應用在 治療表皮皮膚癌細胞上。

並列摘要


Many literatures indicated that indolicidin(IL), one of cationic antimicrobial peptides(CAPs) isolated from the cytoplasmic granules of bovine neutrophils, has broad-spectrum antimicrobial activity. It can inhibit the growth of bacteria, fungi and even viruses. A growing number of studies have shown that some of cationic antimicrobial peptides may own cytotoxic activity against cancer cells. We, therefore, try to investigate the cytotoxic activity of IL and its analogues against human epithelial carcinoma A431and normal human skin cells, HS68 and CRL2309. We vary the concentration of IL and its analogues and investigate the relationship between peptide concentration and cell toxicity. The suitable concentrations may be found to have high activity against human epithelial carcinoma but low cytotoxicity toward normal fibroblasts and keratinocytes. Three concentrations were tested: 60μM, 30μM and 10μM. The result showed that one of the IL analogue, IL-K7F89, has the highest anticancer activity to A431 and the lowest cytotoxic activities toward HS68 and CRL2309 at 10μM. By using PI stain and TUNEL assay, we also found that indolicidin and its analogues kill cells by direct necrosis but not inducing apoptosis. In addition, previous study had indicated that IL-K7F89 has higher antimicrobial but lower hemolytic activity than IL does. Our study further indicated that the IL analogue, IL-K7F89, will also be a good candidate for cancer treatment.

參考文獻


Journal of Structural Biology, 154(1) (2006) 42-58.
[8] Yoon, W. H., Park, H. D., Lim, K., Hwang, B.D., Effect of
[26] Yang Sung-Tae, Shin Song Yub, HahmK Kyung-Soo, Design of
[32] Chilukuri Subbalakshmi, Narasimhaiah Sitaram, Mechanism of
Cell Interaction and Recognition: Therapeutic Aspects, Harwood

延伸閱讀